A new study has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously thought.

Prostate cancer ranks among the most common health challenges men face worldwide. While medical advances continue to improve treatment outcomes, the e ...

Patient-centered pathology reports (PCPR) help patients to understand prostate cancer results better than current stand ...

A new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than ...

Study finds uneven access to prostate cancer clinical trials. While Black men's enrollment was similar to White men, Hispanic ...

Long focused on antioxidants, researchers are now exploring a new route to combat prostate cancer: pro-oxidants.

Discover a study where results from the 2,129 participants revealed that Stockholm3 demonstrated non-inferior sensitivity ...

A novel polygenic risk score (PRS) may be useful for identifying men on active surveillance (AS) for prostate cancer who are ...

Here the authors report the results of a phase 1 trial of PSCA-directed autologous CAR-T cells with pharmacological activation by rimiducid in patients with metastatic pancreatic or prostate cancer.

Israeli Prime Minister Benjamin Netanyahu underwent a successful prostate removal surgery Sunday ... went well and there was “no fear” of cancer or malignancy, The Associated Press reported.

Israeli Prime Minister Benjamin Netanyahu underwent successful surgery Sunday to have his prostate removed ... well and “there was no fear” of cancer or malignancy. “We only hope for ...

Jan. 2, 2025 — A new international study shows that AI-based models can outperform human experts at identifying ovarian cancer in ultrasound ... CAR-T Cells Hold Memories of Past Encounters Jan ...